Tan, Aaron http://orcid.org/0000-0002-3005-3774
Costi, Sara
Morris, Laurel S.
Van Dam, Nicholas T.
Kautz, Marin
Whitton, Alexis E. http://orcid.org/0000-0002-7944-2172
Friedman, Allyson K.
Collins, Katherine A.
Ahle, Gabriella
Chadha, Nisha
Do, Brian
Pizzagalli, Diego A.
Iosifescu, Dan V. http://orcid.org/0000-0002-2512-2835
Nestler, Eric J. http://orcid.org/0000-0002-7905-2000
Han, Ming-Hu
Murrough, James W.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH112081)
Article History
Received: 28 March 2018
Revised: 14 August 2018
Accepted: 3 October 2018
First Online: 1 November 2018
Compliance with ethical standards
:
: In the past 5 years, JWM has provided consultation services to Sage Therapeutics, Boehreinger Ingelheim, Novartis, Allergan, Fortress Biotech, Janssen Research and Development, Genentech, MedAvante-ProPhase, and Global Medical Education (GME) and has received research support from Avanir Pharmaceuticals, Inc. JWM is named on a patent pending for neuropeptide Y as a treatment for mood and anxiety disorders. The Icahn School of Medicine (employer of JWM) is named on a patent and has entered into a licensing agreement and will receive payments related to the use of ketamine if it is approved for the treatment of depression. JWM is not named on this patent and will not receive any payments. KCA has received consulting fees from MedAvante-ProPhase for services unrelated to this study. In the past 3 years, DAP has received consulting fees from Akili Interactive Labs, BlackThorn Therapeutics, Boehreinger Ingelheim, Pfizer, and Posit Science for activities unrelated to the present study. In the past 3 years, DVI has provided consultations to Alkermes, Axsome, MyndAnalytics (CNS Response), Jazz, Lundbeck, Otsuka, and Sunovion and has received research support (through his academic institutions) from Alkermes, Astra Zeneca, Brainsway, LiteCure, Neosync, Roche, and Shire. The other authors declare that they have no conflict of interest.